November 2022

Pasithea Therapeutics Postpones Special Meeting Miami Beach, Fla., Nov. 28, 2022 (GLOBE NEWSWIRE) Introduction Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the discovery, research and development of innovative treatments for central nervous system (“CNS”) disorders, announced that it has postponed its Special Stockholder Meeting originally scheduled for November…

Big News in the Investing World! What’s the Buzz? Hey there, folks! Have you heard the latest news coming out of Wall Street? Pomerantz LLP is currently in the midst of investigating claims on behalf of investors of Lincoln National Corporation, also known as Lincoln on the NYSE. Investors are being advised to reach out…

Breaking News: Treace Medical Concepts Receives FDA Clearance for SpeedPlate™ Rapid Compression Implant Technology The Next Big Thing in Bunion Surgery PONTE VEDRA, Fla., Nov. 28, 2022 (GLOBE NEWSWIRE) — Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI) has just scored a major win in the world of medical technology. The company has…

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Vintage Wine Estates, Inc. (VWE) LOS ANGELES, Nov. 28, 2022 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 13, 2023 deadline to file a lead plaintiff motion in the class action filed…

The global Gastrodin market is expected to rise significantly over the next five years Double Rainbow Announces World’s First Commercial-Scale Biosynthetic Gastrodin, a Natural Marvel Lexington, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) — DoubleRainbow Biosciences (“Double Rainbow”), a sustainable biotech company harnessing bioengineering to improve the quality of human health, today announced the world’s first…

BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Israeli Ministry of Health RESEARCH TRIANGLE PARK, N.C., Nov. 28, 2022 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Israeli Ministry of Health has granted marketing authorization for oral, once-daily ORLADEYO® (berotralstat) to prevent attacks of hereditary angioedema (HAE) in adults and pediatric…

Nabriva Therapeutics Announces Positive Topline Results from Phase 1 Trial of XENLETA® (lefamulin) in Adult Patients PK Data and Safety Profile Consistent with Previous Studies in Healthy Subjects Results Support Potential Utility of Lefamulin in Patients with Cystic Fibrosis DUBLIN, Ireland and FORT WASHINGTON, Pa., Nov. 28, 2022 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ:…

High-Performance Fiber Market Insights and Industry Analysis High-Performance Fiber Market Overview The high-performance fiber market is projected to experience significant growth in the coming years, with a forecasted market size reaching USD 25 billion by 2030 at a CAGR of 8%. Various types of high-performance fibers are driving this growth, including carbon fiber, aramid fiber,…